Terumo (OTCMKTS:TRUMY) Hits New 12-Month Low – What’s Next?

Terumo Corp. (OTCMKTS:TRUMY) shares reached a new 52-week low during trading on Tuesday . The stock traded as low as $12.12 and last traded at $12.1267, with a volume of 49556 shares changing hands. The stock had previously closed at $12.56.

Analyst Ratings Changes

TRUMY has been the topic of several research reports. Nomura raised Terumo to a “hold” rating in a report on Tuesday, February 24th. Zacks Research upgraded Terumo to a “hold” rating in a report on Thursday, April 9th. Two analysts have rated the stock with a Hold rating, According to MarketBeat.com, the company presently has an average rating of “Hold”.

Terumo Price Performance

The firm has a market capitalization of $17.86 billion, a P/E ratio of 20.87 and a beta of 0.62. The company has a current ratio of 1.51, a quick ratio of 0.89 and a debt-to-equity ratio of 0.07. The firm has a 50 day moving average price of $13.13 and a 200-day moving average price of $14.10.

Terumo (OTCMKTS:TRUMY) last released its quarterly earnings results on Friday, February 13th. The company reported $0.14 earnings per share for the quarter, missing the consensus estimate of $0.15 by ($0.01). The company had revenue of $1.94 billion for the quarter, compared to analysts’ expectations of $1.82 billion. Terumo had a net margin of 11.74% and a return on equity of 9.01%. On average, analysts expect that Terumo Corp. will post 0.58 earnings per share for the current year.

Terumo Company Profile

Terumo Corporation (OTCMKTS: TRUMY) is a Japan-based medical technology company that develops, manufactures and markets a broad range of healthcare products for hospitals, clinics and blood centers. Its businesses encompass cardiovascular systems, general hospital products and blood management and cell technologies, supplying devices used in interventional and surgical procedures as well as everyday clinical care. Terumo sells consumables and capital equipment intended to support patient care across acute and ambulatory settings.

Key product categories include vascular access and interventional devices (such as guidewires, catheters and delivery systems), cardiac and cardiopulmonary surgical equipment, infusion therapy products (including infusion pumps and disposables), syringes and blood bags.